Clarence E. Smith - Mar 15, 2022 Form 4 Insider Report for ProtoKinetix, Inc. (PKTX)

Signature
/s/ Clarence E. Smith
Stock symbol
PKTX
Transactions as of
Mar 15, 2022
Transactions value $
$0
Form type
4
Date filed
3/17/2022, 08:34 PM
Previous filing
Dec 28, 2021
Next filing
Mar 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PKTX Common Stock 30M Mar 15, 2022 Direct F1
holding PKTX Common Stock 13.2M Mar 15, 2022 See footnote F2
holding PKTX Common Stock 1.85M Mar 15, 2022 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PKTX Stock Option Award $0 +4.75M $0.00 4.75M Mar 15, 2022 Common Stock 4.75M $0.06 Direct F4
transaction PKTX Warrant Other $0 -143K -100% $0.00* 0 Mar 1, 2022 Common Stock 143K $0.07 Direct F5
holding PKTX Stock Option 25M Mar 15, 2022 Common Stock 25M $0.11 Direct F6
holding PKTX Stock Option 2.6M Mar 15, 2022 Common Stock 2.6M $0.11 Direct F7
holding PKTX Warrant 217K Mar 15, 2022 Common Stock 217K $0.12 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased in a private placement from the Company.
F2 Shares held by the Clarence E. Smith Trusts.
F3 Shares held by Mr. Smith's retirement account.
F4 Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on March 15, 2022. On March 31, 2022, 1,187,500 shares vest; thereafter 1,187,500 shares vest each quarter.
F5 Expiration of warrants with no value received.
F6 Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on August 4, 2021. Fully vested.
F7 Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on August 4, 2021. On September 30, 2021, 650,000 shares vest; thereafter 650,000 shares vest each quarter.